Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$322000.0.

  • RxSight's Other Working Capital Changes fell 324115.7% to -$322000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16000.0, marking a year-over-year increase of 5608.23%. This contributed to the annual value of $1.2 million for FY2024, which is 11886.12% up from last year.
  • As of Q3 2025, RxSight's Other Working Capital Changes stood at -$322000.0, which was down 324115.7% from -$1.5 million recorded in Q2 2025.
  • RxSight's Other Working Capital Changes' 5-year high stood at $2.1 million during Q4 2024, with a 5-year trough of -$1.5 million in Q2 2025.
  • Over the past 5 years, RxSight's median Other Working Capital Changes value was $9680.0 (recorded in 2024), while the average stood at $138324.6.
  • As far as peak fluctuations go, RxSight's Other Working Capital Changes surged by 391000.0% in 2021, and later crashed by 1463692.85% in 2025.
  • Quarter analysis of 5 years shows RxSight's Other Working Capital Changes stood at -$346000.0 in 2021, then soared by 338.15% to $824000.0 in 2022, then surged by 89.2% to $1.6 million in 2023, then surged by 33.42% to $2.1 million in 2024, then crashed by 115.48% to -$322000.0 in 2025.
  • Its Other Working Capital Changes was -$322000.0 in Q3 2025, compared to -$1.5 million in Q2 2025 and -$254000.0 in Q1 2025.